Divi’s Laboratories, Gland Celsus Bio Chemicals and Fidelity have entered the fray to take over Orchid Pharma. Separately, Aurobindo Pharma has completed the acquisition of portfolio of seven marketed oncology injectable products from Spectrum while Motherson Rolling Stock Systems (MRSS) is acquiring Bombardier’s assets in connection with the production and installation of electrical components and systems.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com